+ All Categories
Home > Documents > Donna W. Dorozinsky, RN, MSN, CCRC. Understand that we are not alone in the challenges that we face...

Donna W. Dorozinsky, RN, MSN, CCRC. Understand that we are not alone in the challenges that we face...

Date post: 22-Dec-2015
Category:
View: 214 times
Download: 0 times
Share this document with a friend
Popular Tags:
40
Challenges of Phase I Units in Today’s Changing Environment Donna W. Dorozinsky, RN, MSN, CCRC
Transcript
Page 1: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Challenges of Phase I Units in Today’s

Changing EnvironmentDonna W. Dorozinsky, RN, MSN, CCRC

Page 2: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Understand that we are not alone in the challenges that we face in Phase I

Identify some possible solutions to some of the most challenging issues

Objectives

Page 3: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Pharma sponsored sites Hospital based Healthy male volunteers People writing the studies were part of the Unit’s operation

90 Day FTIM

Where Have We Been?

Page 4: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Budget – What budget? Monitor my study? Are you kidding? Right of first refusal Studies on the shelf Simple molecules

Where Have We Been?

Page 5: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Majority of Phase I studies are independent of Pharma

Cost competitive environment Complex studies Patient studies Professional volunteers Biologics

Where are we today?

Page 6: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Non-scientific anonymous survey Sent to 40 individuals selected through ACPU membership, networks, meeting attendees

16 respondents – Thank You! 21 Operational Challenges 15 Clinical Challenges Some as expected Some Surprises

Identifying the Chanllenges

Page 7: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Demographics of Respondents

Page 8: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Sponsorship

6%

38%

31%

6%

19%

CPU Ownership

Investigator owned Part of a large CRO Part of a small CROPharma sponsored Academic afiliation

Page 9: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Bed Capacity

1-10 11-20 21-40 41-75 76-100 101-150 151+0

0.5

1

1.5

2

2.5

3

3.5

4

Page 10: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Studies in Last 12 Months

1-5 6-10 11-15 16-20 21-25 26-30 31+0

0.5

1

1.5

2

2.5

3

Page 11: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Last minute cancellation of studies by the sponsor◦8 respondents identified in the top 3

Adequate sponsorship funding◦6 respondents identified in top 5

Obtaining studies◦7 respondents identified in top 5◦4 respondents identified as #1 challenge

Greatest Operational Challenges

Page 12: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Recruitment of patient population◦8 respondents identified in top 7

Adequate resources for employee development◦5 sites identified in top 5

Greatest Operational Challenges

Page 13: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Healthy subject recruitment Planning bed occupancy Funding staff training

Equal Distribution Operational Challenges

Page 14: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Complex study designs Ability to function independently of your sponsoring organization

Site security Access to emergency care Storage space

Not Considered to be an Operational Challenge

Page 15: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Cash payment milestones PI recruitment Finding capable monitors knowledgeable in GCPs

Low employee morale Lack of leadership

Additional Operational Challenges

Page 16: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Several clinics phase I-IV have opened in the proximities of the site

Sponsor canceling and postponing the projects.

Staff retention The time to effectively train PRN, agency and night staff on all protocols.

Additional Operational Challenges

Page 17: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Security issues with subjects◦6 respondents identified in the top 5

Contraband◦6 respondents identified in the top 5

Excessive Data Queries◦6 respondents identified in the top 5

Greatest Clinical Challenges

Page 18: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Concern that subjects are participating in multiple studies◦7 respondents identified in the top 5

Abnormal laboratory values◦8 respondents identified in the top 5

Greatest Clinical Challenges

Page 19: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Incomplete delegation logs Missed procedures because of staff shortage

Clinical equipment old or in disrepair

Equal Distribution Clinical Challenges

Page 20: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Emergency response capabilities Illiterate research subjects

Not of Clinical Concern

Page 21: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Ensuring that staff address data issues (corrections)immediately after they are identified

Finding new staff to hire with Phase 1 Clinical Research Experience or even late phase experience that can be trained for Phase 1 staffing

Additional Clinical Concerns

Page 22: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Sponsors don’t understand the challenges of executing these complicated protocols

25.00%

43.75%

18.75%

12.50%

Strongly agreeAgreeNot sureDisagreeStrongly disagree

Page 23: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Monitors are inexperienced in monitoring these complex studies

12.50%

37.50%37.50%

12.50%

Strongly agreeAgreeNot sureDisagreeStrongly disagree

Page 24: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Sponsors are requiring physicians in-house for 24 hours after dosing in some studies

12.50%

18.75%

18.75%25.00%

25.00%

Strongly agreeAgreeNot sureDisagreeStrongly disagree

Page 25: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Quality Checks are built into every step of our operation

56.25%

18.75%

18.75%

6.25%

Strongly agreeAgreeNot sureDisagreeStrongly disagree

Page 26: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Everyone has a disaster plan Everyone has a formal training program that includes an orientation program for new hires

Across the Board

Page 27: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Meeting these Challenges

Page 28: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Recruitment of Patient Population Staff Training Data Queries Security Issues

Some Ideas for Meeting these Challenges

Page 29: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Consider your facilities – are they conducive to patient studies

Build relationships with medical community◦ Physician to physician◦ Ensure physician retains control◦ Provide the administrative support◦ Sub-I opportunity

Take your research to the patient Local health fairs Community support groups NIH partnerships?

Recruitment of Patient Population

Page 30: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Suggestions from the Audience

Page 31: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Build funding into your budgets Training prevents errors – errors cost $$ Annual GCP Training Webinars – one fee for multiple attendees In-house programs

◦ Lunch n Learn◦ Developmental opportunities for presenters

Off-shift training Monthly protocol training PowerPoint Slidesets – specific to clinic

activities

Staff Training

Page 32: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Suggestions from the Audience

Page 33: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Issues◦ High cost - $80/query◦ Tracking◦ Multiple people involved◦ Documenting

Understand causes◦ Monitor knowledge of site and processes◦ Missing source data◦ Careless error◦ Training◦ Lack of staff◦ Missing source data◦ CRF completion

Data Queries

Page 34: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

QA tracking Analysis of data to identify causes that can be addressed

Create information package for monitors

Present findings from tracking to staff

Training based on identified causes

Data Queries

Page 35: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Suggestions from the Audience

Page 36: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

On-site security Your reputation can drive subject behavior

Searches Metal detectors Separation of in patient and out patient areas

Security Issues

Page 37: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Scrubs Lockers away from subject area No cell phones or limited access to cell phones

House Rules Fines for behaviors Be good or be gone

Security Issues

Page 38: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Suggestions from the Audience

Page 39: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Revision to the Survey Wider audience Presentation of results to the ACPU board

◦ Can ACPU take a role in helping sites meet some of these challenges?

Explore other avenues for sharing

Next Steps

Page 40: Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.

Donna [email protected]

Thank You!!!


Recommended